45 related articles for article (PubMed ID: 38507580)
1. Promotion of Th17 Polarized Immunity via Co-Delivery of Mincle Agonist and Tuberculosis Antigen Using Silica Nanoparticles.
Abdelwahab WM; Le-Vinh B; Riffey A; Hicks L; Buhl C; Ettenger G; Jackson KJ; Weiss AM; Miller S; Ryter K; Evans JT; Burkhart DJ
ACS Appl Bio Mater; 2024 Jun; 7(6):3877-3889. PubMed ID: 38832760
[TBL] [Abstract][Full Text] [Related]
2. Probing Isosteric Replacement for Immunoadjuvant Design: Bis-Aryl Triazole Trehalolipids are Mincle Agonists.
Foster MJ; Dangerfield EM; Timmer MSM; Stocker BL; Wilkinson BL
ACS Med Chem Lett; 2024 Jun; 15(6):899-905. PubMed ID: 38894898
[TBL] [Abstract][Full Text] [Related]
3. Lipidated Brartemicin Analogues Are Potent Th1-Stimulating Vaccine Adjuvants.
Foster AJ; Nagata M; Lu X; Lynch AT; Omahdi Z; Ishikawa E; Yamasaki S; Timmer MSM; Stocker BL
J Med Chem; 2018 Feb; 61(3):1045-1060. PubMed ID: 29290115
[TBL] [Abstract][Full Text] [Related]
4. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
[TBL] [Abstract][Full Text] [Related]
5. Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.
Collier MA; Junkins RD; Gallovic MD; Johnson BM; Johnson MM; Macintyre AN; Sempowski GD; Bachelder EM; Ting JP; Ainslie KM
Mol Pharm; 2018 Nov; 15(11):4933-4946. PubMed ID: 30281314
[TBL] [Abstract][Full Text] [Related]
6. Species-Specific Structural Requirements of Alpha-Branched Trehalose Diester Mincle Agonists.
Smith AJ; Miller SM; Buhl C; Child R; Whitacre M; Schoener R; Ettenger G; Burkhart D; Ryter K; Evans JT
Front Immunol; 2019; 10():338. PubMed ID: 30873180
[TBL] [Abstract][Full Text] [Related]
7. Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants.
Dangerfield EM; Ishizuka S; Kodar K; Yamasaki S; Timmer MSM; Stocker BL
J Med Chem; 2024 Apr; 67(7):5373-5390. PubMed ID: 38507580
[TBL] [Abstract][Full Text] [Related]
8. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.
Ong GH; Lian BSX; Kawasaki T; Kawai T
Front Cell Infect Microbiol; 2021; 11():745016. PubMed ID: 34692565
[TBL] [Abstract][Full Text] [Related]
9. Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.
Lang R; Schoenen H; Desel C
Immunobiology; 2011 Nov; 216(11):1184-91. PubMed ID: 21742403
[TBL] [Abstract][Full Text] [Related]
10. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
Hafner AM; Corthésy B; Merkle HP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
[TBL] [Abstract][Full Text] [Related]
11. Vaccine adjuvants: Tailoring innate recognition to send the right message.
Lavelle EC; McEntee CP
Immunity; 2024 Apr; 57(4):772-789. PubMed ID: 38599170
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
